Oral Cancer Screening for Today’s Population:
The Need for Change!
A study released by the National Cancer Institute confirms that HPV oropharyngeal cancers have risen an astounding 225% from 1998 – 2004. If this trend continues, oral cancer will become the nation’s leading HPV-related cancer within the present decade, surpassing cervical cancer. Both the medical and dental communities have been alerted to this emerging pandemic.
We are still not making the inroads required with the majority of oral cancers found in the later stages. Following a comprehensive literature review, the Journal of the American Dental Association released the following statement: “On the basis of the available literature, the authors determined that a COE of mucosal lesions generally is not predictive of histologic diagnosis. The fact that OSCCs often are diagnosed at an advanced stage of disease indicates the need for improving the COE and for developing adjuncts to help detect and diagnose oral mucosal lesions”.
There is an urgent need for change. It’s within our hands.
- To understand the current statistics related to the sexually transmitted Human papillomavirus and its connection with oropharyngeal cancer
- To define high risk anatomical areas related both to HPV and non-HPV oral and oropharyngeal cancer
- To recognize the subtle, life-saving signs and symptoms that may accompany HPV oropharyngeal cancer
- To compare and contrast the value of adjunctive screening devices designed to reveal what may not have been visible with white light examination
President of RDH CONNECTION Inc.
Jo-Anne Jones is a well recognized international speaker bringing life, energy and inspiration to her presentations. Her strong and powerful message leaves dental audiences with a renewed confidence and enthusiasm for the profession they have chosen. She is also a consultant, author and successful entrepreneur. Jo-Anne has been selected by DPR as 1 of the Top 25 Women in Dentistry and continues to be a Dentistry Today CE Leader in 2014.
Jo-Anne is a sought after writer for leading global publications and was PennWell’s award recipient for writing “The Most Important Dental Story Published” last year on the rising incidence of HPV-related oropharyngeal cancer.
Jo-Anne is a Key Opinion Leader for a number of leading corporations within the dental community. She has been described as a very dynamic, knowledgeable and authentic speaker with an ability to powerfully communicate her knowledge. Her frank and open style of lecturing complemented by the provision of clinical resources has earned many loyal followers.
For more information about Jo-Anne Jones, visit www.rdhconnection.com
What People are Saying About Jo-Anne Jones
“Highly authoritative content – Jo-Anne Jones presents the alarming epidemiology of HPV-related oropharyngeal cancer as comprehensively as top scientists in the field and in a way clinicians can understand readily. This disease pattern will change the way we view oral cancer screening in practice. Jo-Anne equips clinicians to understand what they can do now to best serve their patients as continuing research helps us to further understand possible strategies for better risk-based screening and earlier detection.”
Emily Utoft Durand, RDH, RF
Regional Coordinator, National Dental Practice-Based Research Network
“”Jo-Anne Jones was an amazing speaker. She is so passionate about her quest to get this message out on oral cancer. I feel every dental health provider should hear her speak so we can get the word out on sex and oral health and slow this transmission down through education.”
Yankee Dental Meeting, 2014